ASX ANNOUNCEMENT 22 October 2026 Syntro Health engaged to advance Stabl-Im clinical trial formulation • Australian pharmaceutical manufacturing specialist Syntro Health to undertake laboratory formulation activities for the Company’s Stabl-Im investigational product • Engagement represents a...